Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in ovarian platelet-activating factor during ovulation in the gonadotropin-primed immature rat.

L L Espey1, N Tanaka, D S Woodard

  • 1Department of Biology, Trinity University, San Antonio, Texas 78283.

Biology of Reproduction
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lateromedial gradient of the susceptibility of midbrain dopaminergic neurons to neonatal 6-hydroxydopamine toxicity.

Experimental neurology·1995
Same author

Neurotransmitters for the canine inferior pharyngeal constrictor muscle.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1995
Same author

Molecular heterogeneity of PAF in normal human mixed saliva: quantitative mass spectral analysis after direct derivatization of PAF with pentafluorobenzoic anhydride.

Biochimica et biophysica acta·1995
Same author

p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells.

The Journal of biological chemistry·1995
Same author

Cloning of a new cytokine that induces IFN-gamma production by T cells.

Nature·1995
Same author

A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock.

Infection and immunity·1995

Ovarian levels of Platelet-Activating Factor (PAF) decrease significantly during ovulation in rats. This reduction occurs independently of ovulation-blocking drugs, suggesting a specific role for PAF in the ovulatory process.

Area of Science:

  • Reproductive Biology
  • Inflammation and Immunology
  • Biochemistry

Background:

  • Platelet-Activating Factor (PAF) is a phospholipid mediator involved in inflammatory responses and tissue injury.
  • Mammalian ovulation shares biochemical similarities with inflammatory reactions, prompting investigation into PAF's role.
  • Understanding ovarian PAF dynamics is crucial for elucidating the mechanisms of ovulation.

Purpose of the Study:

  • To investigate the changes in ovarian levels of Platelet-Activating Factor (PAF) during the process of ovulation.
  • To determine if PAF levels are altered in response to hormonal induction of ovulation and ovulatory inhibitors.

Main Methods:

  • Ovaries were collected from gonadotropin-primed Wistar rats at 2-hour intervals during induced ovulation.

Related Experiment Videos

  • Lipid extracts were analyzed using thin-layer chromatography (TLC) and a bioassay measuring [3H]-serotonin release from platelets.
  • The effect of indomethacin and epostane on ovarian PAF levels and ovulation was assessed.

    • Main Results:

    • Ovarian PAF levels decreased by 36% within 2 hours after human chorionic gonadotropin (hCG) administration, with a further 14% decline by 4 hours.
    • Ovarian PAF levels remained significantly reduced for up to 24 hours post-hCG.
    • Indomethacin and epostane inhibited ovulation but did not prevent the decline in ovarian PAF; ovarian PAF inhibitors also decreased post-hCG.

    Conclusions:

    • Ovarian levels of Platelet-Activating Factor (PAF) significantly decrease during induced ovulation in rats.
    • The reduction in PAF occurs independently of ovulation inhibition by indomethacin or epostane.
    • These findings suggest a specific role for PAF modulation in the ovulatory process.